Bliss GVS Pharma: 41st AGM Notice & Annual Report Filed

Bliss GVS Pharma Ltd has filed the Notice convening its 41st Annual General Meeting (AGM) and the Annual Report for the financial year 2025-2026. The AGM is scheduled for July 15, 2026, to be held via Video Conference/Other Audio-Visual Means. The company has also fixed July 8, 2026, as the Record Date for determining member entitlement to the final dividend for FY 2025-26. If approved at the AGM, the dividend payment is expected by August 14, 2026. Both the AGM Notice and Annual Report are being sent electronically to members and are available on the company's website.